Found: 74
Select item for more details and to access through your institution.
Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma.
- Published in:
- European Radiology, 2022, v. 32, n. 9, p. 5811, doi. 10.1007/s00330-022-08719-1
- By:
- Publication type:
- Article
Recommendations on multiple testing adjustment in multi-arm trials with a shared control group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cyclin D1 and prognosis in human breast cancer.
- Published in:
- International Journal of Cancer, 1996, v. 69, n. 2, p. 92, doi. 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.0.CO;2-Q
- By:
- Publication type:
- Article
Ductal carcinoma in situ: Assessment of necrosis and nuclear morphology and their association with biological markers.
- Published in:
- Journal of Pathology, 1995, v. 176, n. 4, p. 333, doi. 10.1002/path.1711760404
- By:
- Publication type:
- Article
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open‐label, randomised, phase III trial.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 267, doi. 10.1111/bjh.18600
- By:
- Publication type:
- Article
Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 551, doi. 10.1111/bjh.16793
- By:
- Publication type:
- Article
Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial).
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 573, doi. 10.1111/bjh.15551
- By:
- Publication type:
- Article
Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 6, p. 816, doi. 10.1111/bjh.15459
- By:
- Publication type:
- Article
Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 2, p. 220, doi. 10.1111/bjh.14753
- By:
- Publication type:
- Article
Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 4, p. 573, doi. 10.1111/bjh.14342
- By:
- Publication type:
- Article
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUK one randomized dose selection trial.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 3, p. 336, doi. 10.1111/bjh.13435
- By:
- Publication type:
- Article
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 109, doi. 10.1111/bjh.12861
- By:
- Publication type:
- Article
Improved risk stratification in myeloma using a micro RNA-based classifier.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 3, p. 348, doi. 10.1111/bjh.12394
- By:
- Publication type:
- Article
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.
- Published in:
- Nature Genetics, 2013, v. 45, n. 10, p. 1221, doi. 10.1038/ng.2733
- By:
- Publication type:
- Article
The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
- Published in:
- Nature Genetics, 2013, v. 45, n. 5, p. 522, doi. 10.1038/ng.2583
- By:
- Publication type:
- Article
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.
- Published in:
- Nature Genetics, 2012, v. 44, n. 1, p. 58, doi. 10.1038/ng.993
- By:
- Publication type:
- Article
CONVERGENCE AND DIVERGENCE DURING THE ADAPTATION TO SIMILAR ENVIRONMENTS BY AN AUSTRALIAN GROUNDSEL.
- Published in:
- Evolution, 2013, v. 67, n. 9, p. 2515, doi. 10.1111/evo.12136
- By:
- Publication type:
- Article
Genomic evidence for the parallel evolution of coastal forms in the Senecio lautus complex.
- Published in:
- Molecular Ecology, 2013, v. 22, n. 11, p. 2941, doi. 10.1111/mec.12311
- By:
- Publication type:
- Article
COGNITIVE RESPONSES AND PSYCHIATRIC DISORDER IN WOMEN WITH OPERABLE BREAST CANCER.
- Published in:
- Psycho-Oncology, 1994, v. 3, n. 2, p. 129, doi. 10.1002/pon.2960030207
- By:
- Publication type:
- Article
V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2219, doi. 10.3390/cancers13092219
- By:
- Publication type:
- Article
Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 2, p. 303, doi. 10.1007/s10549-016-3684-4
- By:
- Publication type:
- Article
Berliner Vorlesungen I (1919-1920) - By Paul Tillich. Edited by Erdmann Sturm.
- Published in:
- 2011
- By:
- Publication type:
- Book Review
Berliner Vorlesungen III (1951-1958) - By Paul Tillich. Edited by Erdmann Sturm.
- Published in:
- 2011
- By:
- Publication type:
- Book Review
Vorlesungen Uber Geschichtsphilosophie und Sozialpadagogik (Frankfurt 1929/30) - By Paul Tillich. Edited by Erdmann Sturm.
- Published in:
- 2011
- By:
- Publication type:
- Book Review
Dogmatik (Dresden 1925-1927) - By Paul Tillich. Edited by Werner Schussler and Erdmann Sturm.
- Published in:
- 2011
- By:
- Publication type:
- Book Review
Berliner Vorlesungen II (1920-1924) - By Paul Tillich. Edited by Erdmann Sturm.
- Published in:
- 2011
- By:
- Publication type:
- Book Review
Tillichs frühe Christologie: Eine Untersuchung zu Offenbarung und Geschichte bei Tillich vor dem Hintergrund seiner Schellingrezeption – By Georg Neugebaur.
- Published in:
- 2009
- By:
- Publication type:
- Book Review
Arbeit am Gottebegriff: Band II: Klassiker der Neuzeit – By Joachim Ringleben.
- Published in:
- 2009
- By:
- Publication type:
- Book Review
Expected Net Present Value of Sample Information: From Burden to Investment.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
On Martin Luther's Statement, ' Fides Creatrix Divinitatis'.
- Published in:
- Dialog: A Journal of Theology, 2013, v. 52, n. 3, p. 196, doi. 10.1111/dial.12044
- By:
- Publication type:
- Article
Just Promise: Reformulating Justice as a Practice of the Gift.
- Published in:
- Dialog: A Journal of Theology, 2013, v. 52, n. 2, p. 144, doi. 10.1111/dial.12029
- By:
- Publication type:
- Article
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma.
- Published in:
- Nature Communications, 2016, v. 7, n. 7, p. 12050, doi. 10.1038/ncomms12050
- By:
- Publication type:
- Article
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.
- Published in:
- Nature Communications, 2016, v. 7, n. 1, p. 10290, doi. 10.1038/ncomms10290
- By:
- Publication type:
- Article
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma.
- Published in:
- Nature Communications, 2015, v. 6, n. 4, p. 6997, doi. 10.1038/ncomms7997
- By:
- Publication type:
- Article
P-171: Multistate models provide complementary insights into outcomes for patients treated in the UK NCRI Myeloma XI randomised trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S129, doi. 10.1016/S2152-2650(21)02298-9
- By:
- Publication type:
- Article
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 10, p. 667, doi. 10.1016/j.clml.2021.04.013
- By:
- Publication type:
- Article
OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S10, doi. 10.1016/S2152-2650(21)02089-9
- By:
- Publication type:
- Article
Sequential minimal residual disease (MRD) monitoring: Results from the UK Myeloma XI trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e45, doi. 10.1016/j.clml.2019.09.069
- By:
- Publication type:
- Article
Quadruplet KCRD (Carfilzomib, Cyclophosphamide, Lenalidomide and Dexamethasone) Induction for Newly Diagnosed Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e2, doi. 10.1016/j.clml.2019.09.003
- By:
- Publication type:
- Article
The Impact of Thalidomide, Zoledronate and High-dose Therapy with Autologous Stem Cell Support on Patient Reported Outcomes in Multiple Myeloma: Results of the Quality of Life Substudy of the MRC Myeloma IX Randomised Controlled Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e121, doi. 10.1016/j.clml.2017.03.220
- By:
- Publication type:
- Article
Neutral Tumor Evolution in Myeloma is Associated With Poor Response to Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e10, doi. 10.1016/j.clml.2017.03.017
- By:
- Publication type:
- Article
Integrating Molecular Genetic and Gene Expression Profiling Allows Stratification of Ultra-High Risk Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e1, doi. 10.1016/j.clml.2017.03.003
- By:
- Publication type:
- Article
From Plateau to MRD-Negative CR: Outcomes in the MRC/NCRI Series of Randomised Trials in Newly Diagnosed Patients With Multiple Myeloma From 1980 to 2016.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e60, doi. 10.1016/j.clml.2017.03.110
- By:
- Publication type:
- Article
A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia.
- Published in:
- Trials, 2021, v. 22, n. 1, p. N.PAG, doi. 10.1186/s13063-020-04971-2
- By:
- Publication type:
- Article
A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Active multiple myeloma suppresses and typically eliminates coexisting MGUS.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
- Published in:
- Human Genomics, 2019, v. 13, n. 1, p. N.PAG, doi. 10.1186/s40246-019-0231-5
- By:
- Publication type:
- Article
Luther After Derrida: The Deconstructive Drive of Theology by Marisa Strizzi (review).
- Published in:
- 2024
- By:
- Publication type:
- Book Review
A Harvest of Lutheran Dogmatics: The Life and Work of Twelve Theologians 1960–2020 by Carl E. Braaten (review).
- Published in:
- 2023
- By:
- Publication type:
- Book Review
Radiofrequency ablation ( RFA) of renal cell carcinoma ( RCC): experience in 200 tumours.
- Published in:
- BJU International, 2014, v. 113, n. 3, p. 416, doi. 10.1111/bju.12349
- By:
- Publication type:
- Article